The Economics of the Treatment of Schizophrenia
نویسندگان
چکیده
Prior to the 1980s, economists paid scant attention to schizophrenia, or indeed to mental health in general (1). Early work in the field included efforts to consider the impact of organization and financing on system efficiency and to address the supply of personnel in caring for persons with mental illness. For example, McGuire (2) reviewed the market for psychotherapy and the insurability of mental health care, and Frank (3) examined the supply of psychiatrists. Researchers at RAND analyzed the impact of cost-sharing on demand for mental health care (4). The use of diagnosisrelated groupings to pay for care under prospective payment was considered by Taube and his colleagues (5). Dickey and Goldman (6) reviewed the impact of various funding mechanisms in public mental health. During the 1990s, work on insurance, regulation, and the organization of mental health services continued. Studies of insurance mandates for mental health care, such as Frank and colleagues’ (7) simulation of mandates and related costs, provided valuable information to state legislators considering such laws. Observers of systems change considered major reorganizational efforts, such as those implemented through the Robert Wood Johnson Program on Chronic Mental Illness (8) and other types of organizational reforms (9–12). The 1990s also brought analysis of the increasing implementation of managed care with behavioral health carve-outs (13). These examples of the contributions of mental health
منابع مشابه
Treatment-Responsiveness of Negative Symptoms in Schizophrenia: A double-blind placebo-control clinical trial
Background: The negative symptoms of schizophrenia remain a major clinical challenge. Nortriptyline is a serotonin and noradrenalin reuptake inhibitor and belongs to secondary amine tricycles. The aim of this study is to evaluate the effect of nortriptyline on the negative symptoms of schizophrenia. Methods: This study is a six-week randomized placebo-control trial of nortriptyline or placebo a...
متن کاملHerbal Medicine in the Treatment of Schizophrenia: A Review
As a chronic psychiatric disorder, schizophrenia affects the worldwide population with a lifetime prevalence of 1% and considerable long-term mortality, morbidity, and burden. Besides the adverse effects of routine treatment regimens, a significant portion of patients remain symptomatic despite treatment, especially those with negative symptoms which are the major disabling factors in these pat...
متن کاملRehabilitation of Schizophrenia: At the End or in the Beginning?
The Majority of the long stay psychiatric patients who are in need of rehabilitation suffer from schizophrenia. Most of them enter the old age with this illness, and besides the consequences of schizophrenia, they are facing the deprivation and misery due to the old age. In contrast to the previous decades in which there was no effective treatment for schizophrenia, today with the immediate dia...
متن کاملLow Dose Celecoxib Combined with Clozapine for Treatment of Schizophrenia: A Double Blind Randomized Clinical Trial
Introduction: Higher levels of pro-inflammatory cytokines in schizophrenia have suggested that dysfunctions of the immune system may play a role in this disabling condition. The current study was performed to discover if low dose celecoxib combined with clozapine may improve symptoms of schizophrenia or not. Methods:<span...
متن کاملA Randomized Clinical Trial of Group Cognitive-Rehabilitation Therapy for Patients with Schizophrenia Resistant to Medication
Objectives: Against the background of evidence-based treatments for schizophrenia resistant to medication, the implementation of cognitive-Rehabilitation therapy (CRT) becomes more important, especially about patients who don’t response to medication. There is less evidence for group format and face to face structure of CRT and also for resistant to medication patients. This research investigat...
متن کاملSodium Orthovanadate Treatment Reverses Protracted Methionine Administration Induced Schizophrenia Like Behavior in Rats
Suppression of Akt (Protein kinase B) has been implicated in schizophrenia, the effect which has been documented to be reversed by tyrosine phosphatase inhibition. T hus, present study has been designed to study the effect of sodium orthovanadate, a tyrosine phosphatase inhibitor, on protracted methionine administration induced schizophrenia like behavior in rats. Schizophrenia...
متن کامل